SCHEMBL19293243

SCHEMBL19293243

C=C=CCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
CYP19A1 P11511 4/20 0.46
F7 P08709 3/20 0.46
F3 P13726 3/20 0.46
PPARG P37231 3/20 0.46
OXER1 Q8TDS5 3/20 0.46
PPARA Q07869 3/20 0.46
PTGS1 P23219 3/20 0.46
KMT2A Q03164 2/20 0.46
PPARD Q03181 2/20 0.46
ADORA3 P0DMS8 2/20 0.46
RXRA P19793 2/20 0.46
MAPT P10636 3/20 0.43
NR1I2 O75469 2/20 0.43
PTGS2 P35354 2/20 0.43
FFAR1 O14842 2/20 0.43
CYP3A4 P08684 2/20 0.43
ALOX15 P16050 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TDP1 Q9NUW8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25185271 0.94 ALDH1A1 (0.36) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL25185561 0.89 ALDH1A1 (0.38) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL7161711 0.87 ALDH1A1 (0.41) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL25186138 0.87 ALDH1A1 (0.41) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL25182469 0.87 ALDH1A1 (0.41) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL25178867 0.87 ALDH1A1 (0.41) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL25185231 0.87 ALDH1A1 (0.41) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL5083398 0.82 ALDH1A1 (0.60) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL25181762 0.80 TSHR (0.40) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL25185960 0.80 TRPV1 (0.34) TRPV1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3210972-A1 METHODS OF LOWERING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) Catabasis Pharmaceuticals, Inc. (US) 2017-08-30 EP disclosed